We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.22B
AUM Growth
-$194M
Cap. Flow
-$367M
Cap. Flow %
-5.9%
Top 10 Hldgs %
16.53%
Holding
380
New
29
Increased
159
Reduced
150
Closed
10

Sector Composition

1 Financials 18.81%
2 Healthcare 15.97%
3 Technology 14.53%
4 Industrials 12.87%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OII icon
151
Oceaneering
OII
$4.26B
$12.1M 0.19%
530,013
-210,238
-28% -$5.35M
AAP icon
152
Advance Auto Parts
AAP
$3.17B
$12.1M 0.19%
103,471
-47,185
-31% -$6.48M
WAB icon
153
Wabtec
WAB
$44.6B
$12M 0.19%
131,118
+6,500
+5% +$542K
HAE icon
154
Haemonetics
HAE
$3.54B
$11.8M 0.19%
299,597
-89,021
-23% -$3.66M
DOX icon
155
Amdocs
DOX
$5.64B
$11.7M 0.19%
182,105
+19,781
+12% +$1.25M
FDS icon
156
Factset
FDS
$9.15B
$11.5M 0.19%
69,500
+20,825
+43% +$3.41M
JLL icon
157
Jones Lang LaSalle
JLL
$15.3B
$11.5M 0.19%
92,383
+3,046
+3% +$350K
COO icon
158
Cooper Companies
COO
$14B
$11.5M 0.19%
192,544
+6,960
+4% +$378K
KWR icon
159
Quaker Houghton
KWR
$2.62B
$11.4M 0.18%
78,793
-23,369
-23% -$3.31M
VIVO
160
DELISTED
Meridian Bioscience Inc
VIVO
$11.2M 0.18%
709,363
-226,227
-24% -$3.26M
EW icon
161
Edwards Lifesciences
EW
$49.5B
$11.1M 0.18%
282,450
WFM
162
DELISTED
Whole Foods Market Inc
WFM
$11.1M 0.18%
263,103
-268
-0.1% -$9.76K
FFIV icon
163
F5
FFIV
$23.3B
$10.9M 0.18%
85,968
+2,858
+3% +$374K
EGBN icon
164
Eagle Bancorp
EGBN
$833M
$10.9M 0.17%
171,972
-50,579
-23% -$3.02M
WEX icon
165
WEX
WEX
$5.69B
$10.9M 0.17%
104,371
-30,714
-23% -$3.16M
SBNY
166
DELISTED
Signature Bank
SBNY
$10.8M 0.17%
75,543
+2,299
+3% +$326K
APAM icon
167
Artisan Partners
APAM
$2.73B
$10.8M 0.17%
352,156
-188,120
-35% -$5.41M
SLB icon
168
SLB Ltd
SLB
$70.3B
$10.8M 0.17%
164,041
-7,454
-4% -$534K
AFG icon
169
American Financial Group
AFG
$11.8B
$10.7M 0.17%
108,162
+3,058
+3% +$299K
ENSG icon
170
The Ensign Group
ENSG
$10B
$10.7M 0.17%
525,433
-163,950
-24% -$2.98M
ATRI
171
DELISTED
Atrion Corp
ATRI
$10.7M 0.17%
16,632
-5,397
-24% -$2.9M
AVY icon
172
Avery Dennison
AVY
$12.3B
$10.2M 0.16%
115,180
+3,196
+3% +$268K
TMP icon
173
Tompkins Financial
TMP
$1.35B
$10M 0.16%
127,367
-7,520
-6% -$606K
DEO icon
174
Diageo
DEO
$46.5B
$9.77M 0.16%
81,526
+2,111
+3% +$251K
MLKN icon
175
MillerKnoll
MLKN
$1.48B
$9.64M 0.15%
316,963
-94,411
-23% -$3.01M

Similar funds

Boston Trust Walden's Q2 2017 Portfolio in Review

As of Q2 2017, Boston Trust Walden held 380 positions worth $6.22B, down 3% from $6.42B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Trust Walden withdrew a net $367M in Q2 2017, closing 10 positions and reducing 150 holdings. Its most notable exit was Air Methods Corp, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boston Trust Walden opened a new position in Monro worth $12.7M.

  • Boston Trust Walden's largest Q2 2017 buy was Monro: 303,868 shares worth $12.7M.
  • Boston Trust Walden added most to Alphabet (Google) Class C in Q2 2017, an estimated $18M increase.
  • Boston Trust Walden's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $31.3M.
  • Boston Trust Walden fully exited Air Methods Corp in Q2 2017, selling an estimated $15.4M.
  • Boston Trust Walden's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2017.
  • Boston Trust Walden opened 29 new positions and closed 10 in Q2 2017.
  • Boston Trust Walden's portfolio value fell 3% quarter-over-quarter to $6.22B.

Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.